Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy Ap)
The great success of the previous four CODHy China Congresses held in Shanghai in 2012, 2013, 2016 and 2017 has enabled CODHy to examine and debate the specific issues China and the rest of the world faces in dealing with Diabetes, Obesity and Hypertension and the various methods which Chinese Clinicians and researchers have created in order to tackle these challenges.
As the key nation for the development and execution of new technology, China has led the way for innovation in novel emerging technologies. By collaborating with Israel, the ‘start-up nation’, we will once again explore digital health within the treatment of Diabetes, Obesity and Hypertension to pave the way for future innovations in the field and continue our fruitful collaboration with China. CODHy China will serve as a platform for Digital Companies in the field to present, promote and expand their business opportunities with other companies' partners and organizations.
The CODHy China Congress will once again create a forum for an innovative and unique discussion on digital health in diabetes, obesity and hypertension and will emphasize issues related to epidemiology, genetics, diagnostics, typical complications and distinctive responses to treatments. The scientific program will include the most dynamic and controversial topics facing Chinese and international clinicians in the fields of Diabetes, Obesity and Hypertension in an exciting debate forum.
Bringing together physicians, engineers, high-tech experts and ‘start-ups’ will create an opportunity for all participants to learn and further develop better treatment and create a better future in digital health.
See you at the 5th CODHy China Congress in Shanghai, China!
Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education)
Ticket: USD 200